Summary of Significant Accounting Policies (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2013

Dec. 31, 2012

Accounting Policies [Abstract]

Future amortization expense of patents

For the Years Ending December 31			Harris Patent Portfolio		CompuFill Patent Portfolio		Rockstar Patent Portfolio		Other Costs		Total Amortization
	2013	*	$	11,765	$	10,294	$	247,001	$	10,344	$	279,404
	2014			47,059		41,176		795,348		41,376		924,959
	2015			47,059		41,176		672,310		41,376		801,921
	2016			47,059		41,176		672,310		41,376		801,921
	2017			47,059		41,176		433,918		41,376		563,529
Thereafter				196,077		171,571		1,056,112		172,417		1,596,177
Total			$	396,078	$	346,569	$	3,876,999	$	348,265	$	4,967,911

Antidilutive securities excluded from computation of earnings per share

	September 30, 2013		September 30, 2012
Convertible preferred stock		13,796,852		4
Warrants to purchase common stock		66,062		67,637
Non-vested restricted stock awards		250		-
Options to purchase common stock		2,012,163		2,425
Total		15,875,327		70,066

Discontinued operations

	2012		2011
Revenue	$	728,312	$	820,925
Direct cost and operating expense		(417,428)		(388,065)
Selling, general and administrative expense		(1,279,875)		(816,389)
Loss from discontinued operations before taxes	$	(968,991)	$	(383,529)

Change in level 3 fair value

The following table summarizes the activity of Level 3 inputs measured on a recurring basis for the year ended December 31, 2012:

	Fair Value Measurements of Warrants Using Significant Unobservable Inputs (Level 3)
Balance at December 31, 2011	$	3,125,000
Change in fair value of Warrant Liability		(2,208,000	)
Balance at December 31, 2012	$	917,000

Diluted earning per share Calculation

Diluted earnings per share Calculation	December 31, 2012		December 31, 2011
Net (loss) income	$	(3,857,024)	$	19,585
Less other income from change in fair value of warrants assumed exercised		--		(730,862)
Adjusted net loss	$	(3,857,024)	$	(711,277)
Diluted shares outstanding
Weighted average shares outstanding,		273,567		131,285
Shares assumed exercised		--		7,061
Diluted shares outstanding		273,567		138,346
Net loss per share, diluted	$	(14.10)	$	(5.14)